# Pulmonary Diffusion of Antibiotics in Patients Admitted for ARDS Following SARS-CoV-2 Pneumonia

> **NCT05464680** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 34 (actual)

## Conditions studied

- ARDS
- SARS-CoV 2 Pneumonia

## Interventions

- **OTHER:** blood sample and bronchoalveolar lavage

## Key facts

- **NCT ID:** NCT05464680
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-24
- **Primary completion:** 2025-05-09
- **Final completion:** 2025-05-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05464680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05464680, "Pulmonary Diffusion of Antibiotics in Patients Admitted for ARDS Following SARS-CoV-2 Pneumonia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05464680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*